OpenLegislation

Regulation 54 I1

United Kingdom

For Articles 2 (scope) and 3 (conditions for obtaining a certificate), substitute—

“Article 2

Scope

A product may, under the terms and conditions provided for in this Regulation, be the subject of a certificate if it is—

(a)

protected by a patent; and

(b)

the subject of a UK F1, GB or NI authorisation prior to being placed on the market as a medicinal product.

Article 3

Conditions for obtaining a certificate

Where an application is submitted under Article 7, a certificate shall be granted if, at the date of submission of that application—

(a)

the product is protected by a basic patent in force;

(b)

there is a valid UK F2, GB or NI authorisation to place the product on the market;

(c)

the product has not already been the subject of a certificate;

(d)

the authorisation referred to in point (b) is the first UK F3, GB or NI authorisation to place the product on the market as a medicinal product F4in the territory of the United Kingdom, the territory of England and Wales and Scotland or the territory of Northern Ireland as the case may be.”.

Annotations

Textual amendments

F1

Words in reg. 54 inserted (31.12.2020 immediately before IP completion day) by The Supplementary Protection Certificates (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1471), regs. 1(2), 3(4) (with reg. 7)

F2

Words in reg. 54 inserted (31.12.2020 immediately before IP completion day) by The Supplementary Protection Certificates (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1471), regs. 1(2), 3(5)(a) (with reg. 7)

F3

Words in reg. 54 inserted (31.12.2020 immediately before IP completion day) by The Supplementary Protection Certificates (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1471), regs. 1(2), 3(5)(b)(i) (with reg. 7)

F4

Words in reg. 54 inserted (31.12.2020 immediately before IP completion day) by The Supplementary Protection Certificates (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1471), regs. 1(2), 3(5)(b)(ii) (with reg. 7)

Commencement

I1

Reg. 54 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1